Having completed her PhD at the National Heart and Lung Institute in London, Jill was an academic at the University of Cambridge until December 2011 before founding RxCelerate. Jill offers an insightful strategic vision and provides extensive leadership within the business.
JILL RECKLESS PhD
Following an academic career at Cambridge University, leading a world-renowned group investigating the biology of chronic inflammation, David joined Index Ventures as a Venture Partner, before co-founding leading European Venture Capital house Medicxi in 2015.
DAVID GRAINGER PhD
Nick graduated from the University of Warwick with a degree in Economics. He is a Fellow of the Institute of Chartered Accountants, having trained at EY in London.
He has over 25 year’s experience as a drug discoverer. As a medicinal chemist at GSK from 1990 until 2001 he led both chemistry teams and drug discovery projects across a wide variety of target classes and disease areas from hit to lead to human proof of concept.
NIGEL RAMSDEN PhD
He has worked on novel therapeutics for over 25 years initially at leading academic institutes in the USA and the UK, and since 1996 in a range of biotech and pharma companies. Simon was head of a molecular biology unit in Novartis before founding Iceni BioDiscovery and moving to MedImmune.
SIMON THOMPSON PhD